Tumor Immunology

Branch of  biology concerned with the part of the vulnerable system in the progression and development of cancer is known as Tumor Immunology. The most well know operation is Cancer Immune remedy whereas vulnerable system is used to treat cancer. It also be suggested that Immunosurveillance primarily functions as an element of a more general process of cancer immunoediting.

Immunoediting induces selection for certain excrescence cells, which loose dominant excrescence-specific antigens allowing the excrescence to progress. It has 3 main phases elimination, equilibrium and escape.

  • Carcinogenesis
  • Onco-genomics
  • Cancer Immunology & Immunotherapy
  • Cancer therapeutic resistance
  • Antitumor Effector Cells and Regulation of Tumor Immunity
  • Tumor-Associated Antigen & Immunosuppression
  • Mechanisms of Tumor Rejection and Modulation of Antitumor Responses
  • Pathobiology of Immune System Malignancies
  • Chemotherapy, Radiotherapy & Targeted therapies
  • Drug Development & Vaccines
  • Treatment Approaches for Cancer
  • Specific / Non-specific Immunotherapies
  • Immuno-Oncology studies

    Related Conference of Tumor Immunology

    January 03-04, 2023

    International Congress on HIV-Aids and STD's

    London, UK
    February 15-16, 2023

    11th World Summit on Immunology and Immunotherapy

    Zurich, Switzerland
    February 20-21, 2023

    Global Summit on SARS-CoV-2 virus

    Madrid, Spain
    February 21-22, 2023

    4th European Congress on Hematology

    Zurich, Switzerland
    May 24-25, 2023

    37th International Conference on Immunology

    Vienna, Austria

    Tumor Immunology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in